Estimating the mean and variance from the median, range, and the size of a sample

BMC Medical Research Methodology

Volumn 5, Issue , 2005, Pages

  Hozo, Stela Pudar ^a   Djulbegovic, Benjamin ^b   Hozo, Iztok ^a  

^a INDIANA UNIVERSITY NORTHWEST   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; HUMAN; MATHEMATICAL ANALYSIS; MATHEMATICAL COMPUTING; SAMPLE SIZE; VARIANCE; ANALYSIS OF VARIANCE; CLINICAL TRIAL (TOPIC); COMPUTER SIMULATION; META ANALYSIS (TOPIC); STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

ANALYSIS OF VARIANCE; CLINICAL TRIALS AS TOPIC; COMPUTER SIMULATION; HUMANS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; SAMPLE SIZE;

EID: 21544449115     PISSN: 14712288     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-5-13     Document Type: Article

References (10)

1. Hogg RV, Craig AT: Introduction to mathematical statistics. 5th edition. New York Toronto , Macmillan College Pub. Co. ; Maxwell Macmillan Canada ; Maxwell Macmillan International; 1995:xi, 564.
2. Mood AMF, Graybill FA, Boes DC: Introduction to the theory of statistics. 3d edition. New York, , McGraw-Hill; 1974:xvi, 564.
3. Petiti DB: Meta-analysis, decision analysis and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. 2nd ed. New York , Oxford press; 2000.
4. Rizzo JD, Lichtin AE, Woolf SH, Seidenfeld J, Bennett CL, Cella D, Djulbegovic B, Goode MJ, Jakubowski AA, Lee SJ, Miller CB, Rarick MU, Regan DH, Browman GP, Gordon MS: Use of epoetin in patients with cancer: evidence-based clinical practice guidelines of the American Society of Clinical Oncology and the American Society of Hematology. J Clin Oncol 2002, 20(19):4083-4107.
5. Bohlius J, Langensiepen S, Schwarzer G, Seidenfeld J, Piper M, Bennet C, Engert A: Erythropoietin for patients with malignant disease. Cochrane Database Syst Rev 2004:CD003407..
6. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG: Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials: Comparison of Protocols to Published Articles. JAMA 2004, 291(20):2457-2465.
7. Del Mastro L, Venturini M, Lionetto R, Garrone O, Melioli G, Pasquetti W, Sertoli MR, Bertelli G, Canavese G, Costantini M, Rosso R: Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemia. J Clin Oncol 1997, 15(7):2715-2721.
8. Kunikane H, Watanabe K, Fukuoka M, Saijo N, Furuse K, Ikegami H, Ariyoshi Y, Kishimoto S: Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer. Int J Clin Oncol 2001, 6(6):296-301.
9. Welch RS, James RD, Wilkinson PM, Fb: Recombinant Human Erythropoietin and Platinum-Based Chemotherapy In Advanced Ovarian Cancer. Cancer J Sci Am 1995, 1(4):261.
10. Thatcher N, De Campos ES, Bell DR, Steward WP, Varghese G, Morant R, Vansteenkiste JF, Rosso R, Ewers SB, Sundal E, Schatzmann E, H. S: Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer. Br J Cancer 1999, 80(3-4):396-402.